DAA-1106
http://dbpedia.org/resource/DAA-1106 an entity of type: Thing
DAA-1106 is a drug which acts as a potent and selective agonist at the peripheral benzodiazepine receptor, also known as the mitochondrial 18 kDa translocator protein or TSPO, but with no affinity at the GABAA receptor. It has anxiolytic effects in animal studies. DAA-1106 has a sub-nanomolar binding affinity (Ki) of 0.28nM, and has been used extensively in its 3H or 11C radiolabelled form to map TSPO in the body and brain, which has proved especially helpful in monitoring the progress of neurodegenerative diseases such as Alzheimer's disease.
rdf:langString
rdf:langString
DAA-1106
xsd:integer
23495721
xsd:integer
1084238249
xsd:integer
23
xsd:integer
220551
xsd:integer
8606215
xsd:integer
1
xsd:integer
22
rdf:langString
N--N-acetamide
xsd:double
394.4242
xsd:integer
1
xsd:integer
4
xsd:integer
10430788
rdf:langString
COC1=CC=CC=C1
xsd:integer
1
rdf:langString
DCRZYADKQRHHSF-UHFFFAOYSA-N
xsd:integer
3
xsd:integer
438864385
xsd:integer
200
rdf:langString
DAA-1106 is a drug which acts as a potent and selective agonist at the peripheral benzodiazepine receptor, also known as the mitochondrial 18 kDa translocator protein or TSPO, but with no affinity at the GABAA receptor. It has anxiolytic effects in animal studies. DAA-1106 has a sub-nanomolar binding affinity (Ki) of 0.28nM, and has been used extensively in its 3H or 11C radiolabelled form to map TSPO in the body and brain, which has proved especially helpful in monitoring the progress of neurodegenerative diseases such as Alzheimer's disease. DAA-1106 is used in combination with Positron Emission Tomography (PET) scanning to examine neuroinflammation in vivo.
xsd:nonNegativeInteger
6863
xsd:string
220551-92-8
xsd:string
3A8IVT5Q3P
xsd:string
10430788